87 related articles for article (PubMed ID: 7257484)
1. [Serum immunoglobulin concentrations in Crohn's disease. Clinical relevance and comparison with lipid-A-antibody titers (author's transl)].
Kruis W; Paulus W; Fateh-Moghadam A; Schüssler P; Eisenburg J
Z Gastroenterol; 1981 Jun; 19(6):276-83. PubMed ID: 7257484
[TBL] [Abstract][Full Text] [Related]
2. Circulating lipid A antibodies and their relationship to different clinical conditions of patients with Crohn's disease.
Kruis W; Schussler P; Weinzierl M
Hepatogastroenterology; 1987 Jun; 34(3):123-6. PubMed ID: 3610019
[TBL] [Abstract][Full Text] [Related]
3. [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)].
Schüssler P; Kruis W; Marget W
Med Klin; 1976 Oct; 71(44):1898-902. PubMed ID: 825710
[TBL] [Abstract][Full Text] [Related]
4. [Antibody titer to Bacteroides fragilis is increased in Crohn disease patients with fistula development].
Pietsch M; Brake BA; Schulz TF; Dierich MP
Z Gastroenterol; 1986 May; 24(5):269-75. PubMed ID: 2425502
[TBL] [Abstract][Full Text] [Related]
5. Serum immunoglobulin M concentrations following bowel resection in chronic inflammatory bowel disease.
Soltis RD; Wilson ID
Gastroenterology; 1975 Oct; 69(4):885-92. PubMed ID: 1100468
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
Gao Q; Hogezand RA; Lamers CB; Verspaget HW
Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
[TBL] [Abstract][Full Text] [Related]
7. [Lipid A antibody titers in Crohn's disease (author's transl)].
Schüssler P; Kruis W; Marget W
Klin Wochenschr; 1976 Nov; 54(21):1055-6. PubMed ID: 994458
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G subclasses in Crohn's disease with and without bowel resection.
Bures J; Tichý M; Horácek J; Král B; Sobotka L; Cervenka B; Zadák Z; Komárková O; Fixa B; Pidrman V
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):139-47. PubMed ID: 8159910
[TBL] [Abstract][Full Text] [Related]
9. Absence of complement fixing antibodies against lipopolysaccharides from Escherichia coli in a subgroup of patients with Crohn's disease.
Zeitz M; Hope U; Wust B; Galanos C; Möller B; Lawley TJ; Riecken EO
Gut; 1987 Nov; 28(11):1460-6. PubMed ID: 3322954
[TBL] [Abstract][Full Text] [Related]
10. The immunoglobulin concentrations in serum and bowel secretion in patients with Crohn's disease.
Bergman L; Johansson SG; Krause U
Scand J Gastroenterol; 1973; 8(5):401-6. PubMed ID: 4201737
[No Abstract] [Full Text] [Related]
11. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.
Gouni-Berthold I; Baumeister B; Berthold HK; Schmidt C
Hepatogastroenterology; 1999; 46(27):1720-3. PubMed ID: 10430330
[TBL] [Abstract][Full Text] [Related]
12. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
[TBL] [Abstract][Full Text] [Related]
13. Serum antibodies to mycobacterial antigens in active Crohn's disease.
Kobayashi K; Brown WR; Brennan PJ; Blaser MJ
Gastroenterology; 1988 Jun; 94(6):1404-11. PubMed ID: 2452116
[TBL] [Abstract][Full Text] [Related]
14. Serum angiotensin-converting-enzyme in Crohn's disease.
Nunez-Gornes JF; Tewksbury DA
Am J Gastroenterol; 1981 May; 75(5):384-5. PubMed ID: 6267935
[TBL] [Abstract][Full Text] [Related]
15. [Lipid A antibody titers in patients after ureterosigmoidostomy (author's transl)].
Tunn U; Senge T; Galanos C
Urologe A; 1979 Nov; 18(6):332-4. PubMed ID: 505688
[TBL] [Abstract][Full Text] [Related]
16. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
Maser EA; Villela R; Silverberg MS; Greenberg GR
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
[TBL] [Abstract][Full Text] [Related]
17. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
18. Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease.
Kruis W; Schussler P; Weinzierl M; Galanos C; Eisenburg J
Dig Dis Sci; 1984 Jun; 29(6):502-7. PubMed ID: 6144475
[TBL] [Abstract][Full Text] [Related]
19. Tissue immunoglobulins and early recurrence in Crohn's disease.
Heimann T; Panveliwalla D; Greenstein A; Cohen A; Smith H; Aufses AH
Surg Gynecol Obstet; 1982 Apr; 154(4):541-4. PubMed ID: 7064086
[TBL] [Abstract][Full Text] [Related]
20. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
